Literature DB >> 23814042

A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma.

Maurilio Ponzoni1, Silvia Govi, Giada Licata, Silvia Mappa, Antonio Giordano Resti, Letterio S Politi, Lorenzo Spagnuolo, Eliana Di Cairano, Claudio Doglioni, Andrés J M Ferreri.   

Abstract

Lymphoma is the most common malignancy arising in the ocular adnexa, which includes conjunctiva, lachrymal gland, lachrymal sac, eyelids, orbit soft tissue, and extraocular muscles. Ocular adnexal lymphoma (OAL) accounts for 1%-2% of non-Hodgkin lymphoma and 5%-15% of extranodal lymphoma. Histology, stage, and primary localizations are the most important variables influencing the natural history and therapeutic outcome of these malignancies. Among the various lymphoma variants that could arise in the ocular adnexa, marginal zone B-cell lymphoma (OA-MZL) is the most common one. Other types of lymphoma arise much more rarely in these anatomical sites; follicular lymphoma is the second most frequent histology, followed by diffuse large B-cell lymphoma and mantle cell lymphoma. Additional lymphoma entities, like T-cell/natural killer cell lymphomas and Burkitt lymphoma, only occasionally involve orbital structures. Because they are so rare, related literature mostly consists of anecdotal cases included within series focused on OA-MZL and sporadic case reports. This bias hampers a global approach to clinical and molecular properties of these types of lymphoma, with a low level of evidence supporting therapeutic options. This review covers the prevalence, clinical presentation, behavior, and histological and molecular features of uncommon forms of primary OAL and provides practical recommendations for therapeutic management.

Entities:  

Keywords:  Diffuse large B-cell lymphoma; Follicular lymphoma; Mantle cell lymphoma; Ocular adnexal lymphoma; T-cell lymphoma

Mesh:

Substances:

Year:  2013        PMID: 23814042      PMCID: PMC3720642          DOI: 10.1634/theoncologist.2012-0425

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  109 in total

1.  Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study.

Authors:  Antonio Salar; Nuria Juanpere; Beatriz Bellosillo; Eva Domingo-Domenech; Blanca Espinet; Agustín Seoane; Vicente Romagosa; Eva Gonzalez-Barca; Agustín Panades; Carmen Pedro; Miguel Nieto; Eugenia Abella; Francesc Solé; Aurelio Ariza; Alberto Fernández-Sevilla; Carlos Besses; Sergio Serrano
Journal:  Am J Surg Pathol       Date:  2006-10       Impact factor: 6.394

2.  Eyelid primary diffuse large B-cell lymphoma.

Authors:  Valentín Huerva; Luisa María Canto
Journal:  Can J Ophthalmol       Date:  2008-04       Impact factor: 1.882

3.  Natural killer/T-cell lymphoma with ocular and adnexal involvement.

Authors:  John J Woog; Yoon Duck Kim; R Patrick Yeatts; Stella Kim; Bita Esmaeli; Don Kikkawa; H B Harold Lee; Bobby S Korn; Karim Punja; Thomas M Habermann; Joseph P Colgan; Diva Salomao; J Douglas Cameron
Journal:  Ophthalmology       Date:  2005-12-19       Impact factor: 12.079

4.  Rapidly fatal nasal natural killer/T-cell lymphoma: orbital and ocular adnexal presentations.

Authors:  Salman J Yousuf; Nitin Kumar; Earl D Kidwell; Robert A Copeland
Journal:  Orbit       Date:  2011-03

5.  Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.

Authors:  E L Bollen; R E Brouwer; S Hamers; J Hermans; M Kluin; S U Sankatsing; R V A-Tjak; M V Charvat; J C Kluin-Nelemans
Journal:  Arch Neurol       Date:  1997-07

6.  Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia.

Authors:  T Mannami; T Yoshino; K Oshima; S Takase; E Kondo; N Ohara; H Nakagawa; H Ohtsuki; M Harada; T Akagi
Journal:  Mod Pathol       Date:  2001-07       Impact factor: 7.842

7.  The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma.

Authors:  Ana Mozos; Gaël Roué; Armando López-Guillermo; Pedro Jares; Elias Campo; Dolors Colomer; Antonio Martinez
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

8.  Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.

Authors:  Eun Yoon Cho; Jae Joon Han; Howe Jung Ree; Young Hyeh Ko; Yoon-koo Kang; Hyo Sook Ahn; Seung Do Ahn; Chan Jeoung Park; Jooryung Huh
Journal:  Am J Hematol       Date:  2003-06       Impact factor: 10.047

Review 9.  Ocular adnexal lymphoid tumors: progress in need of clarification.

Authors:  Frederick A Jakobiec
Journal:  Am J Ophthalmol       Date:  2008-04-11       Impact factor: 5.258

Review 10.  Helicobacter pylori: immunoproteomics related to different pathologies.

Authors:  Giulia Bernardini; Daniela Braconi; Paola Lusini; Annalisa Santucci
Journal:  Expert Rev Proteomics       Date:  2007-10       Impact factor: 3.940

View more
  9 in total

1.  Clinical experience on diagnosis and treatment for malignancy originating from the dacryocyst.

Authors:  Li-Juan Zhu; Yu Zhu; Shang-Chen Hao; Pei Huang; Lin-Lin Wang; Xiu-Hong Li; Li-Hong Lian; Ke Zhang
Journal:  Eye (Lond)       Date:  2018-05-30       Impact factor: 3.775

Review 2.  Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Clin Exp Med       Date:  2017-09-22       Impact factor: 3.984

Review 3.  [Lymphoma of the eye and its adnexa : Modern pathological diagnostics and systemic treatment].

Authors:  Falko Fend; Irina Bonzheim; Vinodh Kakkassery; Ludwig M Heindl; Gerald Illerhaus
Journal:  Ophthalmologie       Date:  2022-05-23

4.  A deep learning model combining multimodal radiomics, clinical and imaging features for differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.

Authors:  Xiaoyang Xie; Lijuan Yang; Fengjun Zhao; Dong Wang; Hui Zhang; Xuelei He; Xin Cao; Huangjian Yi; Xiaowei He; Yuqing Hou
Journal:  Eur Radiol       Date:  2022-06-08       Impact factor: 7.034

5.  [Treatment and prognosis of primary ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma: a report from a single center].

Authors:  X Li; J Ye; L Yang; L Q Wei; J Cong; N Yao; J Yang; J W Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-03-14

6.  Conjunctival follicular lymphoma after treatment for invasive squamous cell carcinoma.

Authors:  Laura Pires da Cunha; Jeison Nadai Barros; Marcia Motono; Felipe D'Almeida Costa; Marcelo Carvalho da Cunha; Martha Motono Chojniak
Journal:  Case Rep Ophthalmol       Date:  2014-12-10

7.  Ocular adnexal lymphoma: A single-institution retrospective study.

Authors:  César A Fernández; Roger K Henry; Carol L Shields; Jurij R Bilyk; Sara E Lally; Ralph C Eagle; Tatyana Milman
Journal:  Saudi J Ophthalmol       Date:  2022-04-18

8.  A Primary Bone Diffuse Large B-Cell Lymphoma with Ocular Adnexal Involvement.

Authors:  Rafet Eren; Ceyda Aslan; Cihan Gündoğan; Osman Yokuş; Mehmet Hilmi Doğu; Elif Suyanı
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

9.  Establishment of a combination scoring method for diagnosis of ocular adnexal lymphoproliferative disease.

Authors:  Xiao-Li Qu; Yan Hei; Li Kang; Xin-Ji Yang; Yi Wang; Xiao-Zhong Lu; Li-Hua Xiao; Guang Yang
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.